Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Oral Cavity
Clinical trial NCT02993991 · WITHDRAWN
Trial details
- NCT number
- NCT02993991
- Sponsor
- University Health Network, Toronto
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-10
- Primary completion
- 2017-12-21
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.